Loading clinical trials...
Loading clinical trials...
An Open-label, Randomized, Crossover Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets
Conditions
Interventions
Sotorasib
Locations
4
United States
Labcorp Clinical Research Unit - Daytona Beach
Daytona Beach, Florida, United States
Miami Research Associates LLC - Main Campus / Late Phase
South Miami, Florida, United States
Labcorp Clinical Research Unit - Dallas
Dallas, Texas, United States
Labcorp Clinical Research Unit - Madison
Madison, Wisconsin, United States
Start Date
March 21, 2022
Primary Completion Date
July 17, 2022
Completion Date
July 17, 2022
Last Updated
December 14, 2023
NCT06342713
NCT07310901
NCT07401472
NCT07412353
NCT07280858
NCT07300189
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions